Northern Trust Company of Connecticut’s Accretive Health AH Stock Holding History

Northern Trust Company of Connecticut’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$160K	Sell	17,516 -627	-3%	-$5.39K	﹤0.01%	1819
2013 Q3	$165K	Buy	18,143 +2,059	+13%	+$20.5K	﹤0.01%	1785
2013 Q2	$174K	Buy	+16,084	New	+$169K	﹤0.01%	1728

Other funds holding AH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CII

CR Intrinsic Investors Stamford, Connecticut $2.67B AUM 28.43% 1-Year Est. Return

Northern Trust Company of Connecticut's AH Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Accretive Health (AH) stake by 3.5% in Q4 2013, selling an estimated $5.39K and leaving 17,516 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Northern Trust Company of Connecticut first reported a position in AH in Q2 2013 and has held it in 3 quarters since. The position peaked at $174K in Q2 2013. 85 funds tracked by Wall St. Rank hold AH as of Q4 2013.

Northern Trust Company of Connecticut held 17,516 shares of Accretive Health worth $160K as of Q4 2013.
Northern Trust Company of Connecticut sold 627 Accretive Health shares in Q4 2013, an estimated $5.39K.
Accretive Health made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1819 holding.
Northern Trust Company of Connecticut first reported a position in Accretive Health in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Accretive Health position peaked at $174K in Q2 2013.
85 funds tracked by Wall St. Rank held Accretive Health as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.